Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments
Clinical trial NCT07517315 · TEMPORARILY_NOT_AVAILABLE
Trial details
- NCT number
- NCT07517315
- Sponsor
- Sun Pharma Advanced Research Company Limited
- Status
- TEMPORARILY_NOT_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.